Growth Metrics

Enovis (ENOV) FCF Payout Ratio (2012 - 2014)

Enovis (ENOV) reported FCF Payout Ratio of 0.05 for Q1 2014, up 69.78% year-over-year from 0.03 in Q1 2013, and down 247.23% on a QoQ basis from 0.03 in Q4 2013.

Enovis (ENOV) has 3 years of FCF Payout Ratio data on file, last reported at 0.05 in Q1 2014.

  • Quarterly FCF Payout Ratio rose 69.78% year-over-year to 0.05 in Q1 2014, while the trailing twelve-month figure through Dec 2014 was 0.01 (down 81.77% YoY) and the FY2019 annual result came in at 16.86, changed N/A from the prior year.
  • FCF Payout Ratio retreated to 0.05 in Q1 2014 per ENOV's latest filing, from 0.03 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 0.5 in Q3 2012 and bottomed at 0.16 in Q1 2013.
  • The 3-year median for FCF Payout Ratio is 0.03 (2013), against an average of 0.06.
  • Peak annual rise in FCF Payout Ratio reached 460.84% in 2013, while the deepest fall reached 895.32% in 2013.
  • Tracing ENOV's FCF Payout Ratio over 3 years: stood at 0.12 in 2012, then slumped by 72.78% to 0.03 in 2013, then plunged by 247.23% to 0.05 in 2014.
  • Per Business Quant, the three latest ENOV FCF Payout Ratio figures stand at 0.05 (Q1 2014), 0.03 (Q4 2013), and 0.06 (Q3 2013).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.20
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.81
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.40
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.08
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.25
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 28, 2014 -0.05
Dec 31, 2013 0.03
Sep 27, 2013 0.06
Jun 28, 2013 0.06
Mar 29, 2013 -0.16
Dec 31, 2012 0.12
Sep 28, 2012 0.50
Jun 29, 2012 -0.02
Mar 30, 2012 -0.02